First-in-Human Clinical Trial Marks a Breakthrough for Enginprime's OpusOne™ pVAD #China #Hangzhou #pVAD #Enginprime #OpusOne
0
0
0
0
First-in-Human Clinical Trial Marks a Breakthrough for Enginprime's OpusOne™ pVAD #China #Hangzhou #pVAD #Enginprime #OpusOne
Supira Medical Raises $120M to Propel Innovative Heart Device Market Expansion #United_States #investors #Los_Gatos #Supira_Medical #pVAD